The emergence of Zepbound fueled considerable interest within the medical industry, presenting a remarkably novel method to weight management. This injectable treatment, developed by Novo Nordisk, functions by affecting hunger and promoting feelings of and satisfaction after taking sustenance. Early clinical data suggest considerable weight reducti